|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Research Institute of Medical Sciences, Chonnam National University Medical School, Gwangju 501-746, Republic of Korea; and 2 Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan
Both nitric oxide (NO) and
natriuretic peptides produce apoptosis of vascular smooth
muscle cells. However, there is evidence that NO induces endothelial
cell proliferation, which suggests that there is a difference in the
response of endothelial cells to natriuretic peptides. The purpose of
this study was to investigate the effect of atrial natriuretic peptide
(ANP) on human endothelial cell survival. ANP within the physiological
concentration (10
11 mol/l) induced a 52% increase in the
number of human coronary arterial endothelial cells and a 63% increase
in human umbilical vein endothelial cells at a low concentration of
serum. The increase in cell numbers was blocked by pretreatment with
RP8-CPT-cGMP (RP8), a cGMP-dependent protein kinase inhibitor, with
wortmannin, an Akt/PKB inhibitor, and with PD-98059, an ERK1/2
inhibitor. In a Transwell migration test, ANP also increased the cell
migration, and RP8, wortmannin, and PD-98059 blocked this increase. A
wound healing assay was performed to examine the effects of ANP on
regeneration in vitro. ANP increased both cell numbers and migration,
but the effects were blocked by the above three kinase inhibitors. ANP increased the expression of phospho-Akt and of phospho-ERK1/2 within
1.5 h. These results suggest that ANP can potentiate endothelial regeneration by cGMP-dependent protein kinase stimulation and subsequent Akt and ERK1/2 activations.
cGMP-dependent protein kinase; Akt/protein kinase B; extracellular signal-regulated kinase 1/2
This article has been cited by other articles:
![]() |
F. Hofmann, R. Feil, T. Kleppisch, and J. Schlossmann Function of cGMP-Dependent Protein Kinases as Revealed by Gene Deletion Physiol Rev, January 1, 2006; 86(1): 1 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Wang, M. G. Larson, D. Levy, E. J. Benjamin, E. P. Leip, T. Omland, P. A. Wolf, and R. S. Vasan Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death N. Engl. J. Med., February 12, 2004; 350(7): 655 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Feil, S. M. Lohmann, H. de Jonge, U. Walter, and F. Hofmann Cyclic GMP-Dependent Protein Kinases and the Cardiovascular System: Insights From Genetically Modified Mice Circ. Res., November 14, 2003; 93(10): 907 - 916. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |